Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis

1. Poudel, A, Yates, P, Rowett, D, et al. Use of preventive medication in patients with limited life expectancy: a systematic review. J Pain Symptom Manage 2017; 53: 1097–1110.e1.
Google Scholar | Crossref | Medline2. Todd, A, Husband, A, Andrew, I, et al. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care 2017; 7: 113–121.
Google Scholar | Crossref | Medline3. Morin, L, Todd, A, Barclay, S, et al. Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing? Cancer 2019; 125: 2309–2317.
Google Scholar | Medline4. Morin, L, Aubry, R, Frova, L, et al. Estimating the need for palliative care at the population level: a cross-national study in 12 countries. Palliat Med 2017; 31: 526–536.
Google Scholar | SAGE Journals | ISI5. Wallace, E, McDowell, R, Bennett, K, et al. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci 2016; 72: 271–277.
Google Scholar | Crossref | Medline6. Poudel, A, Peel, NM, Nissen, LM, et al. Adverse outcomes in relation to polypharmacy in robust and frail older hospital patients. J Am Med Dir Assoc 2016; 17: 767.e9–767.e13.
Google Scholar | Crossref | Medline7. Stader, F, Siccardi, M, Battegay, M, et al. Repository describing an aging population to inform physiologically based pharmacokinetic models considering anatomical, physiological, and biological age-dependent changes. Clin Pharmacokinet 2019; 58: 483–501.
Google Scholar | Crossref | Medline8. Corsonello, A, Pedone, C, Incalzi, RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010; 17: 571–584.
Google Scholar | Crossref | Medline | ISI9. Stevenson, J, Abernethy, AP, Miller, C, et al. Managing comorbidities in patients at the end of life. BMJ 2004; 329: 909–912.
Google Scholar | Crossref | Medline10. Reeve, E, Gnjidic, D, Long, J, et al. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 2015; 80: 1254–1268.
Google Scholar | Crossref | Medline | ISI11. Lee, SJ, Leipzig, RM, Walter, LC. Incorporating lag time to benefit into prevention decisions for older adults. JAMA 2013; 310: 2609–2610.
Google Scholar | Crossref | Medline | ISI12. Kutner, JS, Blatchford, PJ, Taylor, DH, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med 2015; 175: 691–700.
Google Scholar | Crossref | Medline | ISI13. Lavan, AH, Gallagher, P, Parsons, C, et al. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 2017; 46: 600–607.
Google Scholar | Medline14. Brisbane South Palliative Care Collaborative . Guide to the pharmacological management of end of life (terminal) symptoms in residential aged care residents, 2013, https://caresearch.com.Au/Caresearch/Portals/0/PA-Tookit/Guide%20_to_the_Pharmacological_Management_of_End_of_Life(Terminal)Symptoms_in_Residential_Aged_Care_Residents.pdf (accessed 10 May 2020).
Google Scholar15. Bush, SH, Tierney, S, Lawlor, PG. Clinical assessment and management of delirium in the palliative care setting. Drugs 2017; 77: 1623–1643.
Google Scholar | Crossref | Medline16. Zaporowska-Stachowiak, I, Stachowiak-Szymczak, K, Oduah, M-T, et al. Haloperidol in palliative care: indications and risks. Biomed Pharmacother 2020; 132: 110772.
Google Scholar | Crossref | Medline17. Masopust, J, Protopopová, D, Vališ, M, et al. Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review. Neuropsychiatr Dis Treat 2018; 14: 1211–1220.
Google Scholar | Crossref | Medline18. Barceló, M, Torres, O, Ruiz, D, et al. Appropriateness of medications prescribed to elderly patients with advanced heart failure and limited life expectancy who died during hospitalization. Drugs Aging 2014; 31: 541–546.
Google Scholar | Crossref | Medline19. McLean, S, Sheehy-Skeffington, B, O’Leary, N, et al. Pharmacological management of co-morbid conditions at the end of life: is less more? Ir J Med Sci 2013; 182: 107–112.
Google Scholar | Crossref | Medline | ISI20. Mullens, W, Damman, K, Harjola, V-P, et al. The use of diuretics in heart failure with congestion – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019; 21: 137–155.
Google Scholar | Crossref | Medline21. Cullinan, S, Raae Hansen, C, Byrne, S, et al. Challenges of deprescribing in the multimorbid patient. Eur J Hosp Pharm 2017; 24: 43–46.
Google Scholar | Crossref | Medline22. Lundby, C, Graabaek, T, Ryg, J, et al. Health care professionals’ attitudes towards deprescribing in older patients with limited life expectancy: a systematic review. Br J Clin Pharmacol 2019; 85: 868–892.
Google Scholar | Crossref | Medline23. Paque, K, Vander Stichele, R, Elseviers, M, et al. Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med 2019; 33: 37–48.
Google Scholar | SAGE Journals | ISI24. Shrestha, S, Poudel, A, Steadman, K, et al. Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: a systematic review. Br J Clin Pharmacol 2020; 86: 1931–1945.
Google Scholar | Crossref | Medline25. Shrestha, S, Poudel, A, Steadman, K, et al. Impact of deprescribing potentially inappropriate dual-purpose medications on patient-related outcomes for older adults with life-limiting illnesses and limited life expectancy: a systematic review, 2020, https://osf.io/ur73q/
Google Scholar26. Thompson, W, Lundby, C, Graabaek, T, et al. Tools for deprescribing in frail older persons and those with limited life expectancy: a systematic review. J Am Geriatr Soc 2019; 67: 172–180.
Google Scholar | Crossref | Medline27. Poudel, A, Berry, R, McCarthy, A, et al. Medication use in older, terminally ill cancer patients: are all medications appropriate? A longitudinal audit. Palliat Med 2019; 33: 1232–1235.
Google Scholar | SAGE Journals | ISI28. Currow, DC, Stevenson, JP, Abernethy, AP, et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590–595.
Google Scholar | Crossref | Medline | ISI29. Van der Meer, HG, Taxis, K, Pont, LG. Changes in prescribing symptomatic and preventive medications in the last year of life in older nursing home residents. Front Pharmacol 2018; 8: 990.
Google Scholar | Crossref | Medline30. Cardona-Morrell, M, Hillman, K. Development of a tool for defining and identifying the dying patient in hospital: criteria for Screening and Triaging to Appropriate aLternative care (CriSTAL). BMJ Support Palliat Care 2015; 5: 78–90.
Google Scholar | Crossref | Medline31. Curtin, D, Jennings, E, Daunt, R, et al. Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria. J Am Geriatr Soc 2020; 68: 762–769.
Google Scholar | Crossref | Medline32. Dalleur, O, Boland, B, Losseau, C, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging 2014; 31: 291–298.
Google Scholar | Crossref | Medline | ISI33. Garfinkel, D, Zur-Gil, S, Ben-Israel, J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9: 430–434.
Google Scholar | Medline | ISI34. Potter, K, Flicker, L, Page, A, et al. Deprescribing in frail older people: a randomised controlled trial. PLoS One 2016; 11: e0149984.
Google Scholar | Crossref35. Bergh, S, Selbæk, G, Engedal, K. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. BMJ 2012; 344: e1566.
Google Scholar | Crossref | Medline36. Pruskowski, JA, Springer, S, Thorpe, CT, et al. Does Deprescribing improve quality of life? a systematic review of the literature. Drugs Aging 2019; 36: 1097–1110.
Google Scholar | Crossref | Medline37. Van Leeuwen, E, Petrovic, M, Van Driel, ML, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 2018; 3: CD007726.
Google Scholar | Medline38. Amblàs-Novellas, J, Murray, SA, Espaulella, J, et al. Identifying patients with advanced chronic conditions for a progressive palliative care approach: a cross-sectional study of prognostic indicators related to end-of-life trajectories. BMJ Open 2016; 6: e012340.
Google Scholar | Crossref | Medline39. Defrancesco, M, Marksteiner, J, Fleischhacker, WW, et al. Use of benzodiazepines in Alzheimer’s disease: a systematic review of literature. Int J Neuropsychopharmacol 2015; 18: pyv055.
Google Scholar | Crossref | Medline40. Cohn, LD, Becker, BJ. How meta-analysis increases statistical power. Psychol Methods 2003; 8: 243–253.
Google Scholar | Crossref | Medline | ISI41. Israel, H, Richter, RR. A guide to understanding meta-analysis. J Orthop Sports Phys Ther 2011; 41: 496–504.
Google Scholar | Crossref | Medline42. Page, AT, Clifford, RM, Potter, K, et al. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol 2016; 82: 583–623.
Google Scholar | Crossref | Medline | ISI43. Kua, C-H, Mak, VSL, Huey Lee, SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc 2019; 20: 362–372.
Google Scholar | Crossref | Medline44. Dionyssiotis, Y . Analyzing the problem of falls among older people. Int J Gen Med 2012; 5: 805–813.
Google Scholar | Crossref | Medline45. Seppala, LJ, van de Glind, EMM, Daams, JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. J Am Med Dir Assoc 2018; 19: 372.e1–372.e8.
Google Scholar46. Fraser, L-A, Liu, K, Naylor, KL, et al. Falls and fractures with atypical antipsychotic medication use: a population-based cohort study. JAMA Intern Med 2015; 175: 450–452.
Google Scholar | Crossref | Medline47. Sera, L, McPherson, ML, Holmes, HM. Commonly prescribed medications in a population of hospice patients. Am J Hosp Palliat Care 2014; 31: 126–131.
Google Scholar | SAGE Journals | ISI48. Heppenstall, CP, Broad, JB, Boyd, M, et al. Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care. Australas J Ageing 2016; 35: E18–E24.
Google Scholar | Crossref | Medline49. Onder, G, Liperoti, R, Foebel, A, et al. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study. J Am Med Dir Assoc 2013; 14: 450.e7–450.e12.
Google Scholar | Crossref50. Curtin, D, Gallagher, P,

留言 (0)

沒有登入
gif